As for clinical relevance, enhancing tumor NM23-H1 expression may potentially be a therapeutic strategy to improve the effectiveness of postoperative radiotherapy for HNSCC patients with cervical metastases. The gene discussed is NME1; the disease is head and neck squamous cell carcinoma.